Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Megalex-PEG Syrup is a veterinary pharmaceutical product developed by Pure Med Farma, primarily used as an osmotic laxative for the treatment of constipation and fecal impaction in livestock and other animals. The active ingredient, polyethylene glycol (PEG), typically in the PEG 3350 form, works by creating an osmotic gradient that draws water into the intestinal lumen. This process increases the volume and moisture content of the stool, stimulating peristalsis and easing evacuation. Unlike stimulant laxatives, PEG is not absorbed by the intestinal mucosa, making it a preferred option for managing gastrointestinal blockages in veterinary medicine without causing systemic side effects or electrolyte imbalances.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on polyethylene glycol 3350 (Puremed Biotech).